Nine pharmaceutical giants just surrendered to Trump's demands, slashing drug prices to match the lowest in the world and ending decades of Americans subsidizing foreign healthcare. This represents the greatest victory for patient affordability in American healthcare history, with massive reductions like diabetes medication dropping from $525 to $55 and asthma inhalers falling from $265 to $89.
The pharmaceutical deals are largely inconsequential to drugmakers' profit margins and won't translate into meaningful discounts for most Americans, who rely on insurance rather than cash payments. Details remain scarce on implementation while Trump's tariff policies have pushed the effective rate to 16.8%, percent, the highest since 1935, contributing to rising prices and economic anxiety.
© 2025 Improve the News Foundation.
All rights reserved.
Version 6.18.0